CellSight Technologies Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $2M

  • Investors
  • 4

CellSight Technologies General Information

Description

Developer of a molecular imaging equipment designed to treat cancer. The company's platform helps in images activated T cells and scans early in the treatment cycle to determine whether a patient's immune system is responding appropriately to their immunotherapy regimen, enabling oncologists to ensure appropriate immune response for patients increasing immunotherapy efficacy.

Contact Information

Website
www.cellsighttech.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 185 Berry Street
  • Suite 350
  • San Francisco, CA 94107
  • United States
+1 (650)
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 185 Berry Street
  • Suite 350
  • San Francisco, CA 94107
  • United States
+1 (650)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CellSight Technologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Grant 01-Jan-2022 $2M Completed Clinical Trials - General
6. Grant 01-Jan-2019 Completed Clinical Trials - General
5. Grant 01-Jan-2018 Completed Clinical Trials - General
4. Grant 21-Sep-2017 Completed Clinical Trials - General
3. Accelerator/Incubator 01-Jan-2016 Completed Clinical Trials - General
2. Grant 01-Jan-2013 $1.75M Completed Clinical Trials - General
1. Accelerator/Incubator Completed Clinical Trials - General
To view CellSight Technologies’s complete valuation and funding history, request access »

CellSight Technologies Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a molecular imaging equipment designed to treat cancer. The company's platform helps in images activated T
Diagnostic Equipment
San Francisco, CA
5 As of 2025

Wichita, KS
 

Oxford, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

CellSight Technologies Competitors (19)

One of CellSight Technologies’s 19 competitors is NeoTherma Oncology, a Venture Capital-Backed company based in Wichita, KS.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
NeoTherma Oncology Venture Capital-Backed Wichita, KS
Blue Earth Diagnostics Formerly VC-backed Oxford, United Kingdom
Navidea Biopharmaceuticals Corporation Dublin, OH
Pyxis Oncology Formerly VC-backed Boston, MA
MTTI (Biotechnology) Accelerator/Incubator Backed West Chester, PA
You’re viewing 5 of 19 competitors. Get the full list »

CellSight Technologies Patents

  • 12

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • 10

    Pending

  • Expiring in next 12 mo

CellSight Technologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023231298-A1 Methods and materials for imaging adipose tissue Pending 11-Mar-2022
EP-4489799-A2 Methods and materials for imaging adipose tissue Pending 11-Mar-2022
US-20220370648-A1 Methods and materials for making pet radiotracers Pending 07-May-2021
AU-2022269605-A1 Methods and materials for making pet radiotracers Pending 07-May-2021
CA-3215228-A1 Methods and materials for making pet radiotracers Pending 07-May-2021 C07H19/16
To view CellSight Technologies’s complete patent history, request access »

CellSight Technologies Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CellSight Technologies Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institutes of Health Government
Springboard Enterprises Accelerator/Incubator
National Cancer Institute Government
QB3 Accelerator/Incubator
To view CellSight Technologies’s complete investors history, request access »

Ready to get started?

Request a free trial

CellSight Technologies FAQs

  • When was CellSight Technologies founded?

    CellSight Technologies was founded in 2009.

  • Where is CellSight Technologies headquartered?

    CellSight Technologies is headquartered in San Francisco, CA.

  • What is the size of CellSight Technologies?

    CellSight Technologies has 5 total employees.

  • What industry is CellSight Technologies in?

    CellSight Technologies’s primary industry is Diagnostic Equipment.

  • Is CellSight Technologies a private or public company?

    CellSight Technologies is a Private company.

  • What is CellSight Technologies’s current revenue?

    The current revenue for CellSight Technologies is .

  • Who are CellSight Technologies’s investors?

    National Institutes of Health, Springboard Enterprises, National Cancer Institute, and QB3 have invested in CellSight Technologies.

  • Who are CellSight Technologies’s competitors?

    NeoTherma Oncology, Blue Earth Diagnostics, Navidea Biopharmaceuticals, Pyxis Oncology, and MTTI (Biotechnology) are some of the 19 competitors of CellSight Technologies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »